Sorafenib-Loaded Long-Circulating Nanoliposomes for Liver Cancer Therapy

Figure 3

The drug-loading efficiency and targeting performance of nanoliposomes. (a) The HPLC chromatogram of standard SOR drugs. (b) The standard curve of SOR drug content. (c) The HPLC chromatogram of SOR drug content in VEGFR-LC-PEG-SOR-NP. (d) The cellular uptake of nanoliposomes determined by flow cytometry. Representative results from three independent experiments are shown.

(a)

(b)

(c)

(d)